斜方肌激痛点活检复合注射疗法治疗肌筋膜疼痛综合征的疗效  

Efficacy of Trigger Point Biopsy Combined with Injection Therapy in the Upper Trapezius Muscle for Myofascial Pain Syndrome

作　　者：郭亚秋[1] 齐峰[1] 胡启雅 王姿[1] 郭静旋[1] 黄海真[1] 丁超[1] 潘新[2] 张力[2] 

机构地区：[1]山东大学齐鲁医院麻醉科,山东济南250012 [2]山东大学齐鲁医院骨外科,山东济南250012

出　　处：《医学与哲学（B）》2014年第12期25-27,共3页Medicine & Philosophy(B)

基　　金：国家自然科学基金资助项目;项目编号:26010105131150

摘　　要：观察斜方肌激痛点活检复合注射疗法治疗肌筋膜疼痛综合征(MPS)的疗效是否优于单纯注射治疗。选择MPS患者60例,随机分为激痛点活检复合镇痛液注射治疗组(BI组)和单纯镇痛液注射治疗组(IT组),每组30例。BI组患者行激痛点活检,并于活检处行镇痛液注射疗法;IT组患者仅于激痛点处行镇痛液注射治疗。评定患者治疗前和治疗后即刻、7天、14天、21天及28天疼痛视觉模拟评分(VAS),治疗后3个月的临床有效率以及和治疗有关的不良反应。结果两组治疗后VAS评分与治疗前相比均降低(P<0.05),从治疗后14天起BI组VAS评分低于IT组(P<0.05)。治疗3个月后BI组有效率高于IT组(P<0.05)。BI组出现1例不良反应患者。激痛点活检复合注射疗法是治疗肌筋膜疼痛综合征有效的方法,且长期疗效优于单纯注射疗法。The aim was to observe the efficacy of trigger point biopsy combined with injection therapy on the upper trapezius muscle for myofascial pain syndrome（MPS）.Sixty patients of MPS were recruited and randomly divided equally into two groups.Group BI groupreceived myofascial trigger point（MTrP）biopsy plus injection therapy and group IT treated with MTrP injection therapy alone.The Visual Analogue Scale（VAS）was measured before the treatment,after the treatment immediately,and the day 7,14,21 and 28after the treatment.The efficacy rate was evaluated up to three months after the treatment.Side effects were also observed during the treatment.The VAS in both groups decreased significantly after treatment（P〈0.05）.The VAS in the group BI decreased significantly as compared to that in the group IT at day 14,21,28 after treatment（P〈0.05）.The effective rate was significantly higher than that in group IT three months after treatment（P〈0.05）.Only one side effect appeared in group BI.Myofascial trigger point biopsy combined with analgesic injection therapy can provide an effective treatment for MPS than injection therapy alone.

关 键 词：肌筋膜疼痛综合征 肌筋膜激痛点 注射 肌肉活检 

分 类 号：R441.1[医药卫生—诊断学]